http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090107954-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
| filingDate | 2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090107954-A |
| titleOfInvention | Pharmaceutical preparations |
| abstract | The present invention provides a controlled release pharmaceutical formulation comprising a prior release compartment comprising telmisartan and a delayed release compartment comprising amlodipine. The present invention is formulated to have the highest drug concentration at the optimal time of expression of each drug by enabling time-dependent absorption of drugs in the body to increase the drug efficacy and reduce side effects, in particular to maintain blood pressure evenly during the risk of complications It is useful for patients with hypertension with complications and those who need to suppress blood pressure during sleep. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107550881-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110237073-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110237073-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180060688-A |
| priorityDate | 2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.